RSLS Company Profile and Key Details
ReShape Lifesciences Inc.
RSLS Stock Price Chart
Stock Price Today
ReShape Lifesciences Inc. (RSLS) stock declined over -4.64%, trading at $3.08 on NASDAQ, down from the previous close of $3.23. The stock opened at $3.32, fluctuating between $2.90 and $3.36 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
San Clemente, CA 92673
United States
Website: https://www.reshapelifesciences.comContact: 949 429 6680About Company
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
Company Information
| Employees | 29 |
| Beta | 1.35 |
| Sales or Revenue | $8.68M |
| 5Y Sales Change% | -0.97% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
ReShape Lifesciences Inc. (NASDAQ: RSLS) stock price is $3.08 in the last trading session. During the trading session, RSLS stock reached the peak price of $3.36 while $2.90 was the lowest point it dropped to. The percentage change in RSLS stock occurred in the recent session was -4.64% while the dollar amount for the price change in RSLS stock was -$0.15.
The NASDAQ listed RSLS is part of Medical - Devices industry that operates in the broader Healthcare sector. ReShape Lifesciences Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Paul F. Hickey
Chief Executive Officer, Pres & Director
Dr. Mark B. Knudson Ph.D.
Co-Founder and Special Advisor to the Chief Executive Officer
Dr. Katherine S. Tweden Ph.D.
Co-Founder
Mr. Dan W. Gladney
Executive Chair
Dr. Dov Gal D.V.M., DVM, M.B.A., MBA
Vice President of Regulatory Clinical Quality & Compliance Officer
Jody B. Dahlman
Director of Communications
Mr. Thomas Stankovich
Chief Financial Officer
Mr. Naqeeb A. Ansari
Senior Vice President of Global Commercial Operations
Mr. Al Diaz
Vice President of Operations and R&D
RSLS's closing price is 9.17% higher than its 52-week low of $2.90 where as its distance from 52-week high of $29.00 is -88.54%.
Number of RSLS employees currently stands at 29.
Official Website of RSLS is: https://www.reshapelifesciences.com
RSLS could be contacted at phone 949 429 6680 and can also be accessed through its website. RSLS operates from 1001 Calle Amanecer, San Clemente, CA 92673, United States.
RSLS stock volume for the day was 68.95K shares. The average number of RSLS shares traded daily for last 3 months was 61.53K.
The market value of RSLS currently stands at $2.20M with its latest stock price at $3.08 and 712.68K of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com